Radio Interviews

The Sheldon Macleod Show discusses the recent trafficking case of Dr. Sarah Jones

Interviews include: Rob Mulloy – GPDOTS enforcement consultant Ray Wagner – Lawyer heading class action suit against Purdue Pharma Nadine Wentzell – Consultant & former narcotics inspector

Radio Interviews

Amy Graves discusses current events related to Rx drug use, addiction, and the pharmaceutical industry – Sheldon Macleod Show – News957

Facts & Data · Video

The Poster Children For OxyContin,15 Years Later.

Published on Sep  9, 2012 by Advocates For The Reform Of Prescription Opioids This video tells the story of two chronic pain patients who were treated with OxyContin. They served as model patients in videos produced by Purdue Pharma, the company that makes OxyContin. At first, OxyContin worked well for them. But eventually they were… Continue reading The Poster Children For OxyContin,15 Years Later.

Video

Leo Glavine Questions The Nova Scotia Minister Of Health About Generic OxyContin

NOTE: The provincial government did make the Prescription Monitoring Program available 24hrs a day but as the Auditor Generals report pointed out pharmacists are not required to enter the information for 30 days.    

Video

Deb Matthews on Canada AM talking about blocking generic OxyContin

Radio Interviews

Robert Perry From Valley Drug Marts Speaks With CBC Info AM

Robert Perry co-owns three Valley Drug Marts in the Annapolis Valley

Ideas to think about · Opinions · Uncategorized

Purdue Pharma’s Hand Seems To Be In Everyones Pocket

In Canada we have the Canadian Guideline For The Safe And Effective Use Of Opioids For Chronic Non Cancer Pain. In November 2007, the National Opioid Use Guideline Group (NOUGG) formed under the umbrella of the Federation of Medical Regulatory Authorities of Canada (FMRAC) with support and/or representation from all provincial and territorial medical regulatory… Continue reading Purdue Pharma’s Hand Seems To Be In Everyones Pocket

My Interviews

Jordi Morgan Talks About N.S. Pulling OxyContin/OxyNeo Funding